Literature DB >> 19635967

Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis.

Joseph Yeboah1, Aaron R Folsom, Gregory L Burke, Craig Johnson, Joseph F Polak, Wendy Post, Joao A Lima, John R Crouse, David M Herrington.   

Abstract

BACKGROUND: Although brachial artery flow-mediated dilation (FMD) predicts recurrent cardiovascular events, its predictive value for incident cardiovascular disease (CVD) events in adults free of CVD is not well established. We assessed the predictive value of FMD for incident CVD events in the Multi-Ethnic Study of Atherosclerosis (MESA). METHODS AND
RESULTS: Brachial artery FMD was measured in a nested case-cohort sample of 3026 of 6814 subjects (mean+/-SD age, 61.2+/-9.9 years) in MESA, a population-based cohort study of adults free of clinical CVD at baseline recruited at 6 clinic sites in the United States. The sample included 50.2% female, 34.3% white, 19.7% Chinese, 20.8% black, and 25.1% Hispanic subjects. Probability-weighted Cox proportional hazards analysis was used to examine the association between FMD and 5 years of adjudicated incident CVD events, including incident myocardial infarction, definite angina, coronary revascularization (coronary artery bypass grafting, percutaneous transluminal coronary angioplasty, or other revascularization), stroke, resuscitated cardiac arrest, and CVD death. Mean (SD) FMD of the cohort was 4.4% (2.8). In probability-weighted Cox models, FMD/unit SD was significantly associated with incident cardiovascular events in the univariate model (adjusted for age and sex) (hazard ratio, 0.79; 95% confidence interval, 0.65 to 0.97; P=0.01), after adjustment for the Framingham Risk Score (FRS) (hazard ratio, 0.80; 95% confidence interval, 0.62 to 0.97; P=0.025), and in the multivariable model (hazard ratio, 0.84; 95% confidence interval, 0.71 to 0.99; P=0.04) after adjustment for age, sex, diabetes mellitus, cigarette smoking status, systolic blood pressure, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, heart rate, statin use, and blood pressure medication use. The c statistic (area under the curve) values of FMD, FRS, and FRS+FMD were 0.65, 0.74, and 0.74, respectively. Compared with the FRS alone, the addition of FMD to the FRS net correctly reclassifies 52% of subjects with no incident CVD event but net incorrectly reclassifies 23% of subjects with an incident CVD event, an overall net correct reclassification of 29% (P<0.001).
CONCLUSIONS: Brachial FMD is a predictor of incident cardiovascular events in population-based adults. Even though the addition of FMD to the FRS did not improve discrimination of subjects at risk of CVD events in receiver operating characteristic analysis, it improved the classification of subjects as low, intermediate, and high CVD risk compared with the FRS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19635967      PMCID: PMC2740975          DOI: 10.1161/CIRCULATIONAHA.109.864801

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  25 in total

1.  Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations?

Authors:  Daniel R Witte; Jan Westerink; Eelco J de Koning; Yolanda van der Graaf; Diederick E Grobbee; Michiel L Bots
Journal:  J Am Coll Cardiol       Date:  2005-06-21       Impact factor: 24.094

2.  Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study.

Authors:  Joseph Yeboah; John R Crouse; Fang-Chi Hsu; Gregory L Burke; David M Herrington
Journal:  Circulation       Date:  2007-04-23       Impact factor: 29.690

3.  Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Stat Med       Date:  2008-01-30       Impact factor: 2.373

Review 4.  Atherosclerosis--an inflammatory disease.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

5.  Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal.

Authors:  Elina Taneva; Katrin Borucki; Lilli Wiens; Ruma Makarova; Caroline Schmidt-Lucke; Claus Luley; Sabine Westphal
Journal:  Am J Cardiol       Date:  2006-02-13       Impact factor: 2.778

6.  The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort.

Authors:  Daichi Shimbo; Cairistine Grahame-Clarke; Yumiko Miyake; Carlos Rodriguez; Robert Sciacca; Marco Di Tullio; Bernadette Boden-Albala; Ralph Sacco; Shunichi Homma
Journal:  Atherosclerosis       Date:  2006-06-08       Impact factor: 5.162

7.  Prognostic value of brachial artery endothelial function and wall thickness.

Authors:  Matthias Frick; Alois Suessenbacher; Hannes F Alber; Wolfgang Dichtl; Hanno Ulmer; Otmar Pachinger; Franz Weidinger
Journal:  J Am Coll Cardiol       Date:  2005-09-20       Impact factor: 24.094

8.  Use and misuse of the receiver operating characteristic curve in risk prediction.

Authors:  Nancy R Cook
Journal:  Circulation       Date:  2007-02-20       Impact factor: 29.690

9.  C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men.

Authors:  Paul M Ridker; Nina P Paynter; Nader Rifai; J Michael Gaziano; Nancy R Cook
Journal:  Circulation       Date:  2008-11-09       Impact factor: 29.690

10.  Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.

Authors:  R Joannides; W E Haefeli; L Linder; V Richard; E H Bakkali; C Thuillez; T F Lüscher
Journal:  Circulation       Date:  1995-03-01       Impact factor: 29.690

View more
  326 in total

1.  Brachial artery diameter and the right ventricle: the Multi-Ethnic Study of Atherosclerosis-right ventricle study.

Authors:  Christopher T Dibble; Daichi Shimbo; R Graham Barr; Emilia Bagiella; Harjit Chahal; Corey E Ventetuolo; David M Herrington; Joao A C Lima; David A Bluemke; Steven M Kawut
Journal:  Chest       Date:  2012-12       Impact factor: 9.410

2.  Bioenergetic effects of mitochondrial-targeted coenzyme Q analogs in endothelial cells.

Authors:  Brian D Fink; Judith A Herlein; Mark A Yorek; Amanda M Fenner; Robert J Kerns; William I Sivitz
Journal:  J Pharmacol Exp Ther       Date:  2012-06-01       Impact factor: 4.030

Review 3.  Endothelial dysfunction and coronary artery disease: assessment, prognosis, and treatment.

Authors:  Yasushi Matsuzawa; Amir Lerman
Journal:  Coron Artery Dis       Date:  2014-12       Impact factor: 1.439

4.  Association between sleep apnea, snoring, incident cardiovascular events and all-cause mortality in an adult population: MESA.

Authors:  Joseph Yeboah; Susan Redline; Craig Johnson; Russell Tracy; Pamela Ouyang; Roger S Blumenthal; Gregory L Burke; David M Herrington
Journal:  Atherosclerosis       Date:  2011-08-22       Impact factor: 5.162

5.  Insulin resistance and incident peripheral artery disease in the Cardiovascular Health Study.

Authors:  Kathryn A Britton; Kenneth J Mukamal; Joachim H Ix; David S Siscovick; Anne B Newman; Ian H de Boer; Evan L Thacker; Mary L Biggs; J Michael Gaziano; Luc Djoussé
Journal:  Vasc Med       Date:  2012-03-08       Impact factor: 3.239

6.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

7.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-12-15       Impact factor: 29.690

8.  Vascular dysfunction and chronic obstructive pulmonary disease: the role of redox balance.

Authors:  Stephen J Ives; Ryan A Harris; Melissa A H Witman; Anette S Fjeldstad; Ryan S Garten; John McDaniel; D Walter Wray; Russell S Richardson
Journal:  Hypertension       Date:  2013-12-09       Impact factor: 10.190

9.  Basic vs More Complex Definitions of Family History in the Prediction of Coronary Heart Disease: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Jaideep Patel; Mahmoud Al Rifai; Maren T Scheuner; Steven Shea; Roger S Blumenthal; Khurram Nasir; Michael J Blaha; John W McEvoy
Journal:  Mayo Clin Proc       Date:  2018-03-16       Impact factor: 7.616

10.  Strong Relationship Between Vascular Function in the Coronary and Brachial Arteries.

Authors:  Ryan M Broxterman; Melissa A Witman; Joel D Trinity; H Jonathan Groot; Matthew J Rossman; Song-Young Park; Simon Malenfant; Jayson R Gifford; Oh Sung Kwon; Soung Hun Park; Catherine L Jarrett; Katherine L Shields; Jay R Hydren; Angela V Bisconti; Theophilus Owan; Anu Abraham; Anwar Tandar; Charles Y Lui; Brigham R Smith; Russell S Richardson
Journal:  Hypertension       Date:  2019-05-06       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.